dementia step ramp study include subjects early results came 65 people rodriguez leyva says hopes offer test years tests development look different possible markers disease blanchette rockefeller neurosciences institute morgantown west virginia group developed measures called pkce levels pkce promotes growth synapses brain destroys tau protein decreases patients alzheimer clinical trials alkon group able predict patients alzheimer 95 percent time measuring pkce levels skin cells validated diagnoses autopsies years later studied 140 patients require findings later phase clinical trials alkon said hopes able offer test public years known -certified lab seek u.s. food drug administration approval lone reliable alzheimer identify